Customization: | Available |
---|---|
Application: | Injection |
Usage Mode: | Injection |
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
The indication of levocarnitine injection is a series of concurrent symptoms caused by secondary carnitine deficiency in patients with chronic renal failure undergoing long-term hemodialysis.
Product Name | Levocatnitine Injection | ||||
Batch No. | Sample | Specification | 5ml:2g | ||
Number | Without | Quantity | 300vials | ||
Test items | Quality Standard | Test Result | |||
Characteristics | Colorless clarity liquid | Complies | |||
Identification | |||||
Identification by HPLC | In the chromatogram recorded under the content determination item, the retention time of the main peak of the test article shall be the same as that of the main peak of the control article | Complies | |||
Inspect | |||||
pH | pH should be 5.5~6.5 | 6.0 | |||
Content Uniformity | Should be meet requirement | Complies | |||
Visible Particles | Should be meet requirement | Complies | |||
Insoluble particles | Should be meet requirement | Complies | |||
Sterile | Should be meet requirement | Complies | |||
Assay | It should be contains levocatnitine 90.0%~110.0% of labeled amount. |
101.40% | |||
Conclusions:The product complies with the requirement of CP standard. | |||||